Skip to main content
FinSpry Logo
FinSpry
RAPP logo
RAPP
(NASDAQ)
Rapport Therapeutics, Inc.
$43.89-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Rapport Therapeutics (RAPP) Stock Price & Financial Analysis

Rapport Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$43.13 - $45.42
52-Week High$52.93
52-Week Low$22.06
Open$45.17
Volume437.73K
Average Volume (3M)290.13K
Market Cap2.07B
Shares Outstanding47.24M
Price to Sales (P/S)103.65
Price to Book (P/B)4.40
EV/EBITDA-16.55
Revenue (TTM)20.00M
Net Income (TTM)-107.28M
Free Cash Flow (TTM)-80.71M
EPS (TTM)$-2.56
Profit Margin-536.39%
Operating Margin-611.03%
Return on Equity (ROE)-22.75%
Debt to Equity0.02
50-Day MA$44.48
200-Day MA$35.00
52-Week Change56.56%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Rapport Therapeutics

What is the current stock price for RAPP?

As of the latest trading session, RAPP stock trades at $43.88. The 52-week range is $22.06–$52.93, with a day range of $43.13–$45.42.

What is the P/E ratio for RAPP?

The P/E ratio (Price-to-Earnings) for RAPP is shown in the Key Statistics section. This valuation metric helps compare Rapport Therapeutics, Inc. to industry peers.

Does RAPP pay dividends?

Rapport Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RAPP?

Based on 1 analyst, the consensus for RAPP is Buy.

What is the market cap of RAPP?

Rapport Therapeutics's market capitalization is $2.07B, classifying it as a mid-cap company. Rapport Therapeutics operates in the Healthcare sector within the Biotechnology industry.